A study published Wednesday in Nature Neuroscience sheds light into how amyloid-beta and tau proteins impact brain activity ...

Researchers evidence suggests it’s the lessening of amyloid-beta in the brain that is behind cognitive decline.

In the past two years, the U.S. Food and Drug Administration has approved two monoclonal antibody treatments to slow ...

Boosting a certain brain protein could help slow the progression of Alzheimer’s disease, a new study has found. The ...

Amyloid-beta and tau proteins have long been associated with Alzheimer's disease. The pathological buildup of these proteins ...

Leqembi and Kisunla don’t just reduce amyloid plaques that are implicated in Alzheimer’s disease. According to new research, ...

Researchers discover how amyloid-β and tau pathologies interact to drive early neurophysiological changes and cognitive ...

The scientists looked at two brain scans and found that areas with more amyloid-beta showed increased brain activity, with ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

Share on Pinterest New research looks into the role of amyloid-beta in developing Alzheimer’s. Westend61/Getty Images A main theory behind the cause of Alzheimer’s disease is the build-up of ...

A main theory behind the cause of Alzheimer’s disease is the build-up of the protein amyloid-beta in the brain. Researchers from the University of Cincinnati provide evidence suggesting it’s ...